- Home
- MCHX vs STRO Comparison
MCHX vs STRO Comparison
Compare MCHX & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCHX
- STRO
- Stock Information
- Founded
- MCHX 2003
- STRO 2003
- Country
- MCHX United States
- STRO United States
- Employees
- MCHX N/A
- STRO N/A
- Industry
- MCHX Business Services
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MCHX Consumer Discretionary
- STRO Health Care
- Exchange
- MCHX Nasdaq
- STRO Nasdaq
- Market Cap
- MCHX 84.3M
- STRO 77.7M
- IPO Year
- MCHX 2004
- STRO 2018
- Fundamental
- Price
- MCHX $2.01
- STRO $0.75
- Analyst Decision
- MCHX
- STRO Hold
- Analyst Count
- MCHX 0
- STRO 7
- Target Price
- MCHX N/A
- STRO $3.97
- AVG Volume (30 Days)
- MCHX 40.7K
- STRO 1.2M
- Earning Date
- MCHX 08-07-2025
- STRO 08-12-2025
- Dividend Yield
- MCHX N/A
- STRO N/A
- EPS Growth
- MCHX N/A
- STRO N/A
- EPS
- MCHX N/A
- STRO N/A
- Revenue
- MCHX $47,951,000.00
- STRO $66,434,000.00
- Revenue This Year
- MCHX $5.77
- STRO N/A
- Revenue Next Year
- MCHX N/A
- STRO N/A
- P/E Ratio
- MCHX N/A
- STRO N/A
- Revenue Growth
- MCHX N/A
- STRO N/A
- 52 Week Low
- MCHX $1.26
- STRO $0.52
- 52 Week High
- MCHX $2.40
- STRO $5.17
- Technical
- Relative Strength Index (RSI)
- MCHX 52.11
- STRO 44.48
- Support Level
- MCHX $2.02
- STRO $0.73
- Resistance Level
- MCHX $2.07
- STRO $0.79
- Average True Range (ATR)
- MCHX 0.10
- STRO 0.06
- MACD
- MCHX -0.03
- STRO 0.00
- Stochastic Oscillator
- MCHX 3.70
- STRO 40.20
About MCHX Marchex Inc. Class B
Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business. It delivers data insights and incorporates artificial intelligence (AI)-powered functionality that drives insights and solutions to help companies find, engage, and support their customers across voice and text-based communication channels. The group enables sales and marketing teams to deliver the buying experiences that today's customers expect. The company generates the majority of its revenues from core analytics and solutions services. The company operates in the United States, Canada, and other countries.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.